Description:
On November 1, the Centers for Medicare and Medicaid Services (CMS) finalized proposed changes to the Physician Fee Schedule and Quality Payment Program for 2019. The final rule includes sections that will be effective on January 1, 2019, and directly address the Protecting Access to Medicare Act (PAMA) and the Clinical Lab Fee Schedule (CLFS). CMS revises the definition of “Applicable Laboratories,” by utilizing the CMS-1450 14x Type of Bill which is specific to hospital outreach laboratories. The use of this bill type will result in an increase in AMP member laboratories required to report private payer data to CMS. During this webinar, an overview of PAMA and the final rule changes will be provided. The webinar will also provide guidance on how to determine whether or not your laboratory qualifies as an applicable laboratory, timelines for collecting and reporting data, and resources available to assist laboratories through this process.
Learning Objectives:
- Explain the new, expanded definition of 'Applicable Laboratories' and provide guidance on determining whether your laboratory qualifies as an applicable laboratory.
- Provide a brief background on PAMA and summarize the first data reporting and collection period.
- Explain the timeline and process for the upcoming data reporting and submission.
- Explain legislative efforts to revise the PAMA requirements and what potential changes mean for AMP members.
Speakers: Erika Miller, JD, Senior Vice President and Counsel, CRD Associates, Consultant to AMP’s Economic Affairs Committee (EAC)
Moderator: Samuel K. Caughron, MD, Chair, AMP Economic Affairs Committee
Duration: 1 hr
Level of Instruction: Basic
Date Recorded: December 20, 2018
Continuing Education Credit Information
CE Credit for this
course has expired.
Note: Members of AMP can access this webinar at no cost. Join the AMP Family!All sales are final. No refunds will be issued.
No digital files may be reproduced or transmitted in any form, by any means, electronic or mechanical. By purchasing a product, you agree to not share any of the course materials, including videos, downloadable slide presentations, outlines, manuscripts, etc. without explicit and written permission from AMP.
